-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - FDA Drug Safety Communication: FDA requires
removal of some prescribing and dispensing restrictions … Highlights of Prescribing Information - Invokana (canagliflozin) tablets, for oral use. 2013
[cited … 2014 July 9]; Available from: https://www.invokanahcp.com/prescribing-
information.pdf.
20. … Highlights of Prescribing Information - Farxiga (dapagliflozin) tablets, for oral use. 2014
[cited … http:www.effectivehealthcare.ahrq.gov
http://www1.astrazeneca
https://www.invokanahcp.com/prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Can Between-Physician Differences in Prescribing Patterns Be Used to
Estimate Treatment Effects?
-
effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
April 23, 2014 - Data Points #19: Medication Use in Medicare
Research Report April 23, 2014 Web Version [NLM Site] Download Main Document PDF 797.2 KB
People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us .
This report is from AHRQ's…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number: 0313
Document Completion Date: 12-12-11
1
Results of Topic Selection Process & Next Steps
Outcomes of serious mental illness will go forward for refinement as a systematic review. The scope of
this topic, including populations, interventions, comparators, and…
-
effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
November 08, 2011 - Current Page Topic Timeline Jun. 27, 2011 Topic Initiated Nov. 8, 2011 Research Protocol Dec. 20, 2012 Systematic Review Jun. 28, 2013 Disposition of Comments Report Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions
Research Protocol Archived November 8, 2011 Download Main Document PDF 173…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - Evidence-based Practice Center Systematic Review Protocol
Page 1 of 25
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Hepatitis C Treatment Adherence
Interventions
I. Background and Objectives for the Systematic Review
Hepatitis C virus (HCV) infe…
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - However, one concern of clinicians is
that IPF is hard to diagnose before prescribing treatment; only … 50% of patients in whom IPF is
diagnosed actually have the disease, which could complicate prescribing … Highlights of prescribing
information: esbriet (pirfenidone) capsules, for oral
use. … Highlights of prescribing information: Ofev
(nintedanib) capsules, for oral use. … doc
Base=renetnt&folderPath=/Prescribing+Information
/PIs/Ofev/ofev.pdf.
32.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
May 13, 2014 - We now reference
the updated prescribing information for injectable
naltrexone. … VIVITROL prescribing information Alkermes, Inc. … Please also note that the VIVITROL prescribing information was recently
updated in 2013. … We now
reference the updated prescribing information. … We now reference
the updated prescribing information.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - We anticipate that wide diffusion would
need to be driven by clinicians prescribing Evzio to patients … concurrently with prescribing
higher doses of opioids for long-trerm pain relief, patients known to … The cost impact of prescribing a naloxone auto-injector for use in the event of overdose in
persons
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/practical-considerations.pdf
March 01, 2022 - CDC
guideline for prescribing opioids for chronic
pain– United States, 2016. … CDC
guideline for prescribing opioids for chronic
pain - United States, 2016. … Reducing the risks of
relief--the CDC opioid-prescribing
guideline.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
January 09, 2020 - What are the effects of prescribing opioid therapy versus not prescribing opioid therapy
for acute episodic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
October 01, 2018 - suggested that such
documents include information on pharmacoogenomics and newer data of how medication
prescribing … utility in health systems with limited
resources, where primary care physicians are diagnosing and prescribing
-
effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
May 19, 2010 - Question 4:
What are the potential adverse effects and/or complications involved with off-label prescribing … First, by reviewing utilization data, surveys on prescribing patterns, and general information about
-
effectivehealthcare.ahrq.gov/system/files/docs/copper_IUDs_birth_control_topic_brief.pdf
December 11, 2020 - Topic Brief: Copper Intrauterine Devices for Birth Control
1
Topic Brief: Copper Intrauterine Devices for Birth Control
Date: 12/09/2020
Nomination Number: 0943
Purpose: This document summarizes the information addressing a nomination submitted on
October 2, 2020 through the Effective Health Care Web…
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-1stplace-qrmedica.pdf
January 01, 2013 - QR Medica Web Site
QR Medica
Home For Clinicians For Patients and Guardians About This Project References
This resource is meant to be used by nurse practitioners, physician assistants and patients alike. For the
providers, the resource contains evidence based care recommendations and clinical tools. Patients …
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - optimize
patient accessibility to treatment by addressing pricing and reimbursement barriers and prescribing … Lorcaserin has been scheduled as a Schedule IV drug, lifting the potential prescribing
limitations … The recommended prescribing by the manufacturer includes an
initial low-titration dosage and a mid-titration … Drug Enforcement Administration as a Schedule IV drug; it
became available for prescribing in June … Prescribing information for Belviq (lorcaserin
hydrochloride) tablets. [internet].
-
effectivehealthcare.ahrq.gov/products/emt-naloxon/research-protocol
November 30, 2016 - risk for overdose. 11,12 The increase in overdoses may be in part a consequence of increased opioid prescribing … Association between opioid prescribing patterns and opioid overdose-related deaths. … A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-protocol.pdf
July 26, 2023 - commonly cited as a key factor.2
Many physicians report that electronic health records (EHRs), electronic prescribing … professional
without direct
patient contact
Interventions
(Exposure)
• EHR
• Electronic prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
January 01, 2023 - Low prescribing rates are thus partly a function
of low overall treatment rates. … Nonetheless, very low prescribing rates for these
medications indicate that primary care providers are … (pg.109) Although
primary care providers are proficient at prescribing a wide variety of medications … Reasons for lack of prescribing are likely multifactorial,
including both patient and physician lack … craving if measured,
interventions (e.g., dose and frequency of administration; type of provider
prescribing